Immediate Hypersensitivity Reactions Differential Diagnoses

  • Author: Miriam K Anand, MD, FAAAAI, FACAAI; Chief Editor: Michael A Kaliner, MD   more...
 
Updated: Apr 21, 2010
 
 

Differential Diagnoses

Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Miriam K Anand, MD, FAAAAI, FACAAI  Consulting Staff, Department of Allergy/Immunology, Allergy Associates and Lab, Ltd

Miriam K Anand, MD, FAAAAI, FACAAI is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American College of Allergy, Asthma and Immunology, American College of Physicians-American Society of Internal Medicine, and American Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

John M Routes, MD  Professor of Pediatrics, Medicine, Microbiology and Molecular Genetics, Chief, Section of Allergy and Clinical Immunology, Department of Pediatrics, Medical College of Wisconsin

John M Routes, MD, is a member of the following medical societies: Alpha Omega Alpha, American Academy of Allergy Asthma and Immunology, American Association of Immunologists, American College of Allergy, Asthma and Immunology, American Society for Microbiology, American Society for Virology, Clinical Immunology Society, and Federation of American Societies for Experimental Biology

Disclosure: Nothing to disclose.

Specialty Editor Board

Stephen Rosenfeld, MD  Professor Emeritus, Department of Medicine, Allergy, Immunology and Rheumatology Unit, University of Rochester School of Medicine and Dentistry

Stephen Rosenfeld, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Association of Immunologists, American Federation for Clinical Research, Clinical Immunology Society, and Medical Society of the State of New York

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Michael R Simon, MD, MA  Clinical Professor Emeritus, Departments of Internal Medicine and Pediatrics, Wayne State University School of Medicine; Adjunct Staff, Division of Allergy and Immunology, Department of Internal Medicine, William Beaumont Hospital

Michael R Simon, MD, MA is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American College of Allergy, Asthma and Immunology, American College of Physicians, American Federation for Medical Research, Michigan Allergy and Asthma Society, Michigan State Medical Society, Royal College of Physicians and Surgeons of Canada, and Society for Experimental Biology and Medicine

Disclosure: Secretory IgA, Inc. Ownership interest Management position

Timothy D Rice, MD  Associate Professor, Departments of Internal Medicine and Pediatrics and Adolescent Medicine, St Louis University School of Medicine

Timothy D Rice, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Physicians

Disclosure: Nothing to disclose.

Chief Editor

Michael A Kaliner, MD  Clinical Professor of Medicine, George Washington University School of Medicine; Chief, Section of Allergy and Immunology, Washington Hospital Center; Medical Director, Institute for Asthma and Allergy

Michael A Kaliner, MD is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American Association of Immunologists, American College of Allergy, Asthma and Immunology, American Society for Clinical Investigation, American Thoracic Society, and Association of American Physicians

Disclosure: Alcon Consulting fee Consulting; Greer Consulting fee Consulting; Sanofi Consulting fee Consulting; Schering/Merck Consulting fee Consulting; Teva Consulting fee Consulting; Meda Honoraria Speaking and teaching; Ista Consulting

References

  1. Gell PGH, Coombs RRA, eds. Clinical Aspects of Immunology. Oxford, England: Blackwell; 1963.

  2. Sell S, Rich RR, Fleisher TA, et al, eds. Clinical Immunology: Principles and Practice. ed. St. Louis, Mo: Mosby-Year Book; 1996:449-77.

  3. Lawlor GJ, Fischer TJ, Adelman DC, eds. Manual of Allergy and Immunology. 3rd ed. Philadelphia, Pa: Lippincott-Raven; 1995.

  4. Nimmagadda SR, Evans R 3rd. Allergy: etiology and epidemiology. Pediatr Rev. Apr 1999;20(4):111-5; quiz 116. [Medline].

  5. Middleton E, Reed C, Ellis E, eds. Allergy: Principles and Practice. 5th ed. St. Louis, Mo: Mosby-Year Book; 1998.

  6. Paul WE. Fundamental Immunology. 2nd ed. Columbus, Ohio: Primis Custom Publishing; 1999.

  7. Xystrakis E, Boswell SE, Hawrylowicz CM. T regulatory cells and the control of allergic disease. Expert Opin Biol Ther. Feb 2006;6(2):121-33. [Medline].

  8. Busse WW, Coffman RL, Gelfand EW, et al. Mechanisms of persistent airway inflammation in asthma. A role for T cells and T-cell products. Am J Respir Crit Care Med. Jul 1995;152(1):388-93. [Medline].

  9. von Bubnoff D, Geiger E, Bieber T. Antigen-presenting cells in allergy. J Allergy Clin Immunol. Sep 2001;108(3):329-39. [Medline].

  10. Fukuoka Y, Xia HZ, Sanchez-Muñoz LB, Dellinger AL, Escribano L, Schwartz LB. Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5. J Immunol. May 1 2008;180(9):6307-16. [Medline].

  11. Brunnée T, Reddigari SR, Shibayama Y, Kaplan AP, Silverberg M. Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions. Clin Exp Allergy. Jun 1997;27(6):653-63. [Medline].

  12. Noga O, Brunnée T, Schäper C, Kunkel G. Heparin, derived from the mast cells of human lungs is responsible for the generation of kinins in allergic reactions due to the activation of the contact system. Int Arch Allergy Immunol. Dec 1999;120(4):310-6. [Medline].

  13. Pearlman DS. Pathophysiology of the inflammatory response. J Allergy Clin Immunol. Oct 1999;104(4 Pt 1):S132-7. [Medline].

  14. Busse WW. Mechanisms and advances in allergic diseases. J Allergy Clin Immunol. Jun 2000;105(6 Pt 2):S593-8. [Medline].

  15. Schoenwetter WF. Allergic rhinitis: epidemiology and natural history. Allergy Asthma Proc. Jan-Feb 2000;21(1):1-6. [Medline].

  16. Akinbami LJ. Asthma Prevalence, Health Care Use and Mortality: United States, 2003-2005. Hyattsville, Md: National Center for Health Statistics; 2006.

  17. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. May 2004;59(5):469-78. [Medline].

  18. Janson C, Anto J, Burney P, et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J. Sep 2001;18(3):598-611. [Medline].

  19. Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. Mar 1995;8(3):483-91. [Medline].

  20. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. Aug 26 2006;368(9537):733-43. [Medline].

  21. Lawson JA, Senthilselvan A. Asthma epidemiology: has the crisis passed?. Curr Opin Pulm Med. Jan 2005;11(1):79-84. [Medline].

  22. Keller MB, Lowenstein SR. Epidemiology of asthma. Semin Respir Crit Care Med. Aug 2002;23(4):317-29. [Medline].

  23. Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax. Jan 2007;62(1):91-6. [Medline].

  24. Lasley MV. Allergic disease prevention and risk factor identification. Immunol Allergy Clin North Am. 1999;19:149-59.

  25. von Mutius E, Braun-Fahrländer C, Schierl R, Riedler J, Ehlermann S, Maisch S. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy. Sep 2000;30(9):1230-4. [Medline].

  26. Centers for Disease Control and Prevention (CDC). Compressed Mortality File, CDC WONDER. Atlanta, Ga: CDC; 2006.

  27. Grant EN, Lyttle CS, Weiss KB. The relation of socioeconomic factors and racial/ethnic differences in US asthma mortality. Am J Public Health. Dec 2000;90(12):1923-5. [Medline].

  28. Guinnepain MT, Eloit C, Raffard M, Brunet-Moret MJ, Rassemont R, Laurent J. Exercise-induced anaphylaxis: useful screening of food sensitization. Ann Allergy Asthma Immunol. Dec 1996;77(6):491-6. [Medline].

  29. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy. Nov 1995;25 Suppl 2:74-8; discussion 95-6. [Medline].

  30. Stock P, DeKruyff RH, Umetsu DT. Inhibition of the allergic response by regulatory T cells. Curr Opin Allergy Clin Immunol. Feb 2006;6(1):12-6. [Medline].

  31. Nelson HS. Immunotherapy for inhalant allergens. In: Adkinson NF, Bochner BS, Busse WW, Holgate ST, Lemanske RF, Simons FE. Middleton's Allergy Principles and Practice. Vol 2. 7th ed. Philadelphia, Pa: Elsevier; 2009:1672-3.

  32. Weber RW. Immunotherapy with allergens. JAMA. Dec 10 1997;278(22):1881-7. [Medline].

  33. Francis JN, Till SJ, Durham SR. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol. Jun 2003;111(6):1255-61. [Medline].

  34. Ruffin CG, Busch BE. Omalizumab: a recombinant humanized anti-IgE antibody for allergic asthma. Am J Health Syst Pharm. Jul 15 2004;61(14):1449-59. [Medline].

  35. Davis LA. Omalizumab: a novel therapy for allergic asthma. Ann Pharmacother. Jul-Aug 2004;38(7-8):1236-42. [Medline].

  36. Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol. Aug 2001;108(2):184-90. [Medline].

  37. Spergel JM, Leung DY. Safety of topical calcineurin inhibitors in atopic dermatitis: evaluation of the evidence. Curr Allergy Asthma Rep. Jul 2006;6(4):270-4. [Medline].

  38. Breuer K, Werfel T, Kapp A. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Am J Clin Dermatol. 2005;6(2):65-77. [Medline].

  39. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol. Nov 2001;108(5):871-3. [Medline].

  40. Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol. Jan 1998;101(1 Pt 1):33-7. [Medline].

  41. Leung DY, Sampson HA, Yunginger JW, Burks AW Jr, Schneider LC, Wortel CH. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med. Mar 13 2003;348(11):986-93. [Medline].

  42. Schatz M, Zeiger RS. Allergic disease during pregnancy: current treatment options. J Resp Dis. 1998;19:834-42.

  43. Haahtela T, Lindholm H, Björkstén F, Koskenvuo K, Laitinen LA. Prevalence of asthma in Finnish young men. BMJ. Aug 4 1990;301(6746):266-8. [Medline].

  44. Johansson-Lindbom B, Borrebaeck CA. Germinal center B cells constitute a predominant physiological source of IL-4: implication for Th2 development in vivo. J Immunol. Apr 1 2002;168(7):3165-72. [Medline].

  45. Keeley DJ, Neill P, Gallivan S. Comparison of the prevalence of reversible airways obstruction in rural and urban Zimbabwean children. Thorax. Aug 1991;46(8):549-53. [Medline].

  46. Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest. Dec 2001;108(12):1865-73. [Medline].

  47. Novalbos A, Sastre J, Cuesta J, De Las Heras M, Lluch-Bernal M, Bombín C. Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins. Clin Exp Allergy. Mar 2001;31(3):438-43. [Medline].

  48. Platts-Mills TA. The role of immunoglobulin E in allergy and asthma. Am J Respir Crit Care Med. Oct 15 2001;164(8 Pt 2):S1-5. [Medline].

  49. Strachan DP, Wong HJ, Spector TD. Concordance and interrelationship of atopic diseases and markers of allergic sensitization among adult female twins. J Allergy Clin Immunol. Dec 2001;108(6):901-7. [Medline].

  50. Wilson AM, Haggart K, Sims EJ, Lipworth BJ. Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis. Clin Exp Allergy. Oct 2002;32(10):1504-9. [Medline].

 
Previous
Next
 
Immediate hypersensitivity reactions. Sensitization phase of an immunoglobulin E–mediated allergic reaction.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.